发明授权
- 专利标题： Therapeutic agent for cancer
- 专利标题（中）： 癌症治疗剂
-
申请号： US12449377申请日： 2008-02-07
-
公开(公告)号： US09045556B2公开(公告)日： 2015-06-02
- 发明人: Keiko Udaka , Masahide Ishibashi
- 申请人： Keiko Udaka , Masahide Ishibashi
- 申请人地址： JP Tokyo JP Osaka JP Kochi
- 专利权人： NEC Corporation,The Research Foundation for Microbial Disease of Osaka University,National University Corporation Kochi University
- 当前专利权人： NEC Corporation,The Research Foundation for Microbial Disease of Osaka University,National University Corporation Kochi University
- 当前专利权人地址： JP Tokyo JP Osaka JP Kochi
- 代理机构： Wenderoth, Lind & Ponack, L.L.P.
- 优先权： JP2007-028081 20070207
- 国际申请： PCT/JP2008/052070 WO 20080207
- 国际公布： WO2008/096831 WO 20080814
- 主分类号： A61K39/10
- IPC分类号： A61K39/10 ; A61K39/00 ; A61K39/04 ; C07K14/47 ; A61K39/02
摘要：
The present invention provides an adjuvant for cancer antigen peptide vaccines and virus antigen peptides, containing a pertussis vaccine as a primary ingredient. The present invention also provides a therapeutic agent for a cancer or viral infectious disease, and a prophylactic agent for metastasis or recurrence of cancer or onset of virus-induced tumor, containing a cancer antigen peptide or virus antigen peptide and a pertussis vaccine. A pertussis vaccine that can be suitably used is a whole cell body pertussis vaccine. The agents of the present invention can be safely administered in a plurality of doses.
公开/授权文献
- US20100322968A1 THERAPEUTIC AGENT FOR CANCER 公开/授权日：2010-12-23
信息查询
